Carpe luz—seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium
- 31 October 2005
- journal article
- editorial
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 62 (4) , 499-503
- https://doi.org/10.1016/j.gie.2005.07.017
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventionsGastrointestinal Endoscopy, 2005
- Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trialGastrointestinal Endoscopy, 2005
- Advances in Barrett’s Esophagus and Esophageal AdenocarcinomaGastroenterology, 2005
- Barrett’s esophagus: A molecular perspectiveCurrent Gastroenterology Reports, 2005
- Present Status of Photodynamic Therapy for High-Grade Dysplasia in Barrett??s EsophagusJournal of Clinical Gastroenterology, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Epidemiologic trends in esophageal and gastric cancer in the United StatesSurgical Oncology Clinics of North America, 2002
- p53 Protein Overexpression in Low Grade Dysplasia (LGD) in Barrett's Esophagus: Immunohistochemical Marker Predictive of ProgressionAmerican Journal of Gastroenterology, 2001
- The Diagnosis of Low-Grade Dysplasia in Barrett's Esophagus and Its Implications for Disease ProgressionAmerican Journal of Gastroenterology, 2000
- Is there publication bias in the reporting of cancer risk in Barrett's esophagus?Gastroenterology, 2000